K G Koura1, A D Harries2, P I Fujiwara3, R A Dlodlo3, E K Sansan4, B Kampoer5, D Affolabi6, A Combary7, V Mbassa8, H Gando9, A Bangoura10, M Assao11, B Gning12, M F Dogo13, A Fiogbé6, G Bridgen3. 1. International Union Against Tuberculosis and Lung Disease (The Union), Paris, France, Communauté d´universités et établissements (COMUE) Sorbonne Paris Cité, Université Paris Descartes, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France, École Nationale de Formation des Techniciens Supérieurs en Santé Publique et en Surveillance Epidémiologique, Université de Parakou, Parakou, Benin. 2. International Union Against Tuberculosis and Lung Disease (The Union), Paris, France, Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK. 3. International Union Against Tuberculosis and Lung Disease (The Union), Paris, France. 4. Alliance Côte d´Ivoire, Abidjan, Côte d´Ivoire. 5. Dynamique de la Réponse d´Afrique Francophone sur la TB (DRAF TB), Yaoundé, Cameroon. 6. Ministry of Health, National Tuberculosis Programme, Cotonou, Benin. 7. Ministry of Health, National Tuberculosis Programme, Ouagadougou, Burkina Faso. 8. Ministry of Health, National Tuberculosis Programme, Yaoundé, Cameroon. 9. Ministry of Health, National Tuberculosis Programme, Bangui, Central African Republic. 10. Ministry of Health, National Tuberculosis Programme, Conakry, Guinea. 11. Ministry of Health, National Tuberculosis Programme, Niamey, Niger. 12. Ministry of Health, National Tuberculosis Programme, Dakar, Senegal. 13. Ministry of Health, National Tuberculosis Programme, Lomé, Togo, <email></email>, Email: kgkoura@theunion.org.
Authors: D S Graciaa; R R Kempker; E Sanikidze; S Tukvadze; L Mikiashvili; R Aspindzelashvili; D Alkhazashvili; H M Blumberg; Z Avaliani; N Tukvadze Journal: Int J Tuberc Lung Dis Date: 2021-03-01 Impact factor: 2.373